Baillie Gifford & CO Royalty Pharma PLC Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

A detailed history of Baillie Gifford & CO transactions in Royalty Pharma PLC stock. As of the latest transaction made, Baillie Gifford & CO holds 16,122,491 shares of RPRX stock, worth $426 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

16,122,491

Previous 16,352,759 1.41%

Holding current value

$426 Million

Previous $431 Million 5.77%

% of portfolio

0.35%

Previous 0.34%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$25.63 - $29.27 $5.9 Million - $6.74 Million	-230,268 Reduced 1.41%	16,122,491 $456 Million
Q2 2024 Jul 25, 2024	SELL	$26.26 - $29.9 $8.14 Million - $9.27 Million	-310,033 Reduced 1.86%	16,352,759 $431 Million
Q1 2024 May 01, 2024	SELL	$27.46 - $31.33 $25.5 Million - $29.1 Million	-927,658 Reduced 5.27%	16,662,792 $506 Million
Q4 2023 Jan 26, 2024	SELL	$26.21 - $29.22 $17.1 Million - $19 Million	-650,834 Reduced 3.57%	17,590,450 $494 Million
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $6.81 Million - $8.14 Million	-259,304 Reduced 1.4%	18,241,284 $495 Million
Q2 2023 Jul 28, 2023	SELL	$29.6 - $36.56 $12.4 Million - $15.3 Million	-418,162 Reduced 2.21%	18,500,588 $569 Million
Q1 2023 May 03, 2023	BUY	$32.77 - $39.4 $59 Million - $70.9 Million	1,799,468 Added 10.51%	18,918,750 $682 Million
Q4 2022 Jan 24, 2023	SELL	$39.17 - $44.04 $29.3 Million - $33 Million	-748,893 Reduced 4.19%	17,119,282 $677 Million
Q3 2022 Oct 27, 2022	SELL	$39.88 - $44.65 $5.05 Million - $5.66 Million	-126,743 Reduced 0.7%	17,868,175 $718 Million
Q2 2022 Aug 08, 2022	BUY	$37.53 - $44.22 $633 Million - $746 Million	16,867,887 Added 1496.67%	17,994,918 $757 Million
Q1 2022 May 05, 2022	BUY	$37.46 - $42.44 $42.2 Million - $47.8 Million	1,127,031 New	1,127,031 $43.9 Million

Others Institutions Holding RPRX

# of Institutions

414

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Royalty Pharma PLC Transaction History